Timing of Adjunctive Therapy in the Treatment of Depression: A Chart Review

Abstract

Introduction: The objective of this study was to examine the evolution of antidepressant switch and adjunctive therapy.

Methods: This chart review was conducted at 6 primary psychiatric clinics or hospitals, in Tokyo, Japan. A chart review of longitudinal prescriptions was conducted regarding 633 outpatients with major depressive disorder for up to 2 years after their first visit. Patients who had already received antidepressants prior to the visit were excluded.

Results: 22.6% (N=143) of the patients completed or continued the outpatient treatment over the 2 years while 27 (4.3%), 23 (3.6%), and 439 (69.4%) patients discontinued it due to hospitalization, referral to another clinic, and loss to follow-up, respectively. A total of 597 episodes of antidepressant treatment were identified. Among them, 482 episodes (80.7%) were associated with the suggested dose ranges while antidepressant drugs were under-dosed in 19.3% (N=115) of the episodes. 50 patients (7.9%) received adjunctive therapy; it was employed after a median of only one antidepressant had been tried.

Conclusion: Psychiatrists may be hasty in prescribing an adjunctive therapy in the treatment of depression.

Key words

antidepressants - adjunctive therapy - depression

• References

• 1 Andersson Sundell K, Petzold MG, Wallerstedt SM. Factors associated with switching and combination use of antidepressants in young Swedish adults. Int J Clin Pract 2013; 67: 1302-1310
• 2 Lam RW, Kennedy SH, Grigoriadis S et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 2009; 117 (Suppl. 01) S26-S43
• 3 Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry. 11^th edition. Chichenster: Wiley-Blackwell; 2012
• 4 American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. Third Edition. American Psychiatric Association; 2010
• 5 Uchida H, Takeuchi H, Graff-Guerrero A et al. Dopamine D2 receptor occupancy and clinical effects: a systematic review and pooled analysis. J Clin Psychopharmacol 2011; 31: 497-502
• 6 Zhang JP, Gallego JA, Robinson DG et al. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 2013; 16: 1205-1218
• 7 Sakurai H, Bies RR, Stroup ST et al. Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data. Schizophr Bull 2013; 39: 564-574
• 8 Ray WA, Chung CP, Murray KT et al. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360: 225-235
• 9 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO; 1992
• 10 Vaccheri A, Dall’Olio R, Gaggi R et al. Antidepressant versus neuroleptic activities of sulpiride isomers on four animal models of depression. Psychopharmacology 1984; 83: 28-33
• 11 Pinto Jr LR, Alves RC, Caixeta E et al. New guidelines for diagnosis and treatment of insomnia. Arq Neuropsiquiatr 2010; 68: 666-675
• 12 Kishi T, Meltzer HY, Matsuda Y et al. Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis. Psychol Med 2013; 1-15
• 13 Uchida H, Suzuki T, Mamo DC et al. Effects of age and age of onset on prescribed antipsychotic dose in schizophrenia spectrum disorders: a survey of 1,418 patients in Japan. Am J Geriatr Psychiatry 2008; 16: 584-593
• 14 Uchida H, Suzuki T, Mamo DC et al. Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan. J Anxiety Disord 2009; 23: 477-481